Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 8282009)

1.

Monoclonal antibodies against a phencyclidine derivative are used to investigate protein-ligand interactions.

Casalotti SO, Kozikowski AP, Fauq A, Tückemantel W, Krueger KE.

Eur J Pharmacol. 1993 Oct 15;247(2):209-13.

PMID:
8282009
2.

Design of an irreversible affinity ligand for the phencyclidine recognition site on N-methyl-D-aspartate-type glutamate receptors.

Casalotti SO, Kozikowski AP, Fauq A, Tückmantel W, Krueger KE.

J Pharmacol Exp Ther. 1992 Jan;260(1):21-8.

PMID:
1530974
3.

Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.

Hirbec H, Mausset AL, Kamenka JM, Privat A, Vignon J.

J Neurosci Res. 2002 May 1;68(3):305-14.

PMID:
12111860
4.

Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor.

Owens SM, Zorbas M, Lattin DL, Gunnell M, Polk M.

J Pharmacol Exp Ther. 1988 Aug;246(2):472-8.

PMID:
2457075
5.

Haloperidol binding to monoclonal antibodies: conformational analysis and relationships to D-2 receptor binding.

Sherman MA, Linthicum DS, Bolger MB.

Mol Pharmacol. 1986 Jun;29(6):589-98.

PMID:
2423865
7.

Synthesis and pharmacological evaluation of 4a-phenanthrenamine derivatives acting at the phencyclidine binding site of the N-methyl-D-aspartate receptor complex.

Bigge CF, Malone TC, Hays SJ, Johnson G, Novak PM, Lescosky LJ, Retz DM, Ortwine DF, Probert AW Jr, Coughenour LL, et al.

J Med Chem. 1993 Jul 9;36(14):1977-95.

PMID:
8336337
8.

Pharmacodynamics of a monoclonal antiphencyclidine Fab with broad selectivity for phencyclidine-like drugs.

Hardin JS, Wessinger WD, Proksch JW, Owens SM.

J Pharmacol Exp Ther. 1998 Jun;285(3):1113-22.

9.
10.

The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor.

Roth BL, Gibbons S, Arunotayanun W, Huang XP, Setola V, Treble R, Iversen L.

PLoS One. 2013;8(3):e59334. doi: 10.1371/journal.pone.0059334. Epub 2013 Mar 19.

11.
13.

Amphetamine inhibits the N-methyl-D-aspartate receptor-mediated responses by directly interacting with the receptor/channel complex.

Yeh GC, Chen JC, Tsai HC, Wu HH, Lin CY, Hsu PC, Peng YC.

J Pharmacol Exp Ther. 2002 Mar;300(3):1008-16.

14.

Ethanol-induced inhibition of [3H]thienylcyclohexylpiperidine (TCP) binding to NMDA receptors in brain synaptic membranes and to a purified protein complex.

Michaelis EK, Chen X, Joseph DB, Hurlbert M, Kumar KN, Michaelis ML.

J Neurochem. 1996 Jul;67(1):201-11.

PMID:
8666993
15.

[Preparation and identification of monoclonal antibodies against human programmed cell death 10 (PDCD10)].

Chen YY, Zhao YG, Zhang T, Xu LJ, Ma X, Zhao HS, Chen YY.

Beijing Da Xue Xue Bao. 2006 Dec 18;38(6):586-91. Chinese.

17.
18.
19.

The antidepressant metapramine is a low-affinity antagonist at N-methyl-D-aspartic acid receptors.

Boireau A, Bordier F, Durand G, Doble A.

Neuropharmacology. 1996;35(12):1703-7.

PMID:
9076749
20.

Production and characterization of monoclonal antibodies to pituitary adenylate cyclase activating polypeptide type I receptor.

Zvirblienë A, Zvirblis G, Cao YJ, Fahrenholz F.

Hybridoma. 1999 Aug;18(4):335-42.

PMID:
10571263
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk